Nutraceutical Potential of Five Mexican Brown Seaweeds.
Clicks: 330
ID: 83481
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
330 views
33 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #47 of 269 articles by views in BioMed research international
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 269 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
In search of pharmaceutically active products to control type 2 diabetes, five brown seaweeds (, , , , and ) from the Northwest Mexican Pacific coast were investigated. Proximate composition and total polyphenol content (TPC) as phloroglucinol equivalents (PGE) were determined for the five seaweed powders and their respective hydroethanolic (1 : 1) extracts. Extracts were screened for their radical scavenging activity (DPPH and ORAC) and glycosidase inhibitory activity. HPLC-DAD, HPLC-MS-TOF, and ATR-FT-IR methodologies were used to identify the most abundant phlorotannins and sulfated polysaccharides in the extracts. Hydroethanolic extracts contained minerals (17 to 59% of the dry matter), proteins (4 to 9%), ethanol-insoluble polysaccharides (5.4 to 53%), nitrogen-free extract (NFE) (24.4 to 70.1%), lipids (5 to 12%), and TPC (2.6 to 47.7 g PGE per 100 g dry extract). and dry extracts presented the lowest ash content (26 and 17%, respectively) and had some of the highest phenolic (47.7 and 15.2 g PGE per 100 g extract), NFE (57.3 and 70.1%), and soluble polysaccharide (19.7 and 53%) contents. and extracts had the highest antioxidant activity (IC DPPH 1.7 and 3.7 mg mL; ORAC 0.817 and 0.801 mmol Trolox equivalent/g extract) and the highest -amylase and -glucosidase inhibitory capacities (IC 940 and 1152 g mL against -amylase and 194 and 647 g mL against -glucosidase). The most abundant phlorotannins identified in the extracts were phloretol, fucophloroethol, and two- and three-phloroglucinol unit (PGU) phlorotannins. Laminarin, fucoidan, and alginate were among the sulfated polysaccharides identified in the extracts. The bioactivities of and extracts were mainly related with their contents of three PGU phlorotannins and sulfated polysaccharides (e.g., fucoidan, laminarin, and alginate). These results suggest and are potential candidates for food products and nutraceutical and pharmaceutical preparations, and as additives for diabetes management.
| Reference Key |
mzquiz-de-la-garza2019nutraceuticalbiomed
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Múzquiz de la Garza, Ana Rocío;Tapia-Salazar, Mireya;Maldonado-Muñiz, Maribel;de la Rosa-Millán, Julián;Gutiérrez-Uribe, Janet Alejandra;Santos-Zea, Liliana;Barba-Dávila, Bertha Alicia;Ricque-Marie, Denis;Cruz-Suárez, Lucía Elizabeth; |
| Journal | BioMed research international |
| Year | 2019 |
| DOI |
10.1155/2019/3795160
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.